Siliq (brodalumab) / Kyowa Kirin, LEO Pharma, Bausch Health, AstraZeneca  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

   Remove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Siliq (brodalumab) / Bausch Health
NCT04368403: A Study of KHK4827 in Patients With Systemic Sclerosis

Active, not recruiting
1
8
Japan
KHK4827
Kyowa Kirin Co., Ltd.
Systemic Sclerosis
01/19
02/24

Download Options